Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts 
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave 
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
Bill Ackman Eyes New Fund to Bet Against Market Complacency 
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 
Chinese Cars in Europe: Consumer Trust Is Shifting Fast 
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion 
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth 
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy 
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG 
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58% 
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home 
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20 
OpenAI Addresses Security Vulnerability in macOS App Certification Process 
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses 
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 
 announced by Shareholders Foundation - EconoTimes)
SAN DIEGO, Oct. 02, 2017 -- The Shareholders Foundation, Inc. announces that a deadline is coming up on October 3, 2017 in the lawsuit that was filed for certain investors in Envision Healthcare Corp (NYSE:EVHC) shares over alleged Securities Laws Violations by Envision Healthcare Corp.
Investors who purchased shares of Envision Healthcare Corp (NYSE:EVHC) have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff claims that the defendants made false and/or misleading statements and/or failed to disclose that EmCare routinely arranged for patients who sought treatment at in-network facilities to be treated by out-of-network physicians, that EmCare accordingly billed these patients at higher rates than if the patients had received treatment from in-network physicians, that the Company's statements attributing EmCare's Class Period growth to other factors were therefore false and/or misleading, that Envision's EmCare revenues were likely to be unsustainable after the foregoing conduct came to light, and that as a result of the foregoing, Envision's public statements were materially false and misleading at all relevant times.
Those who purchased Envision Healthcare Corp (NYSE:EVHC) shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
